vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and VERRA MOBILITY Corp (VRRM). Click either name above to swap in a different company.

VERRA MOBILITY Corp is the larger business by last-quarter revenue ($223.6M vs $209.8M, roughly 1.1× MYRIAD GENETICS INC). On growth, VERRA MOBILITY Corp posted the faster year-over-year revenue change (0.1% vs -0.4%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs 0.3%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Verra Mobility Corp is a leading global smart mobility technology solution provider. It delivers toll management, parking and traffic compliance enforcement, connected vehicle services, and fleet management tools, serving government transport agencies, rental car operators, commercial fleet owners, and automotive partners across North America, Europe, and Asia-Pacific.

MYGN vs VRRM — Head-to-Head

Bigger by revenue
VRRM
VRRM
1.1× larger
VRRM
$223.6M
$209.8M
MYGN
Growing faster (revenue YoY)
VRRM
VRRM
+0.5% gap
VRRM
0.1%
-0.4%
MYGN
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
0.3%
VRRM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MYGN
MYGN
VRRM
VRRM
Revenue
$209.8M
$223.6M
Net Profit
$26.7M
Gross Margin
70.0%
Operating Margin
-2.7%
23.2%
Net Margin
12.0%
Revenue YoY
-0.4%
0.1%
Net Profit YoY
-17.3%
EPS (diluted)
$-0.09
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
VRRM
VRRM
Q1 26
$223.6M
Q4 25
$209.8M
$257.9M
Q3 25
$205.7M
$261.9M
Q2 25
$213.1M
$236.0M
Q1 25
$195.9M
$223.3M
Q4 24
$210.6M
$221.5M
Q3 24
$213.3M
$225.6M
Q2 24
$211.5M
$222.4M
Net Profit
MYGN
MYGN
VRRM
VRRM
Q1 26
$26.7M
Q4 25
$18.9M
Q3 25
$-27.4M
$46.8M
Q2 25
$-330.5M
$38.6M
Q1 25
$-100.0K
$32.3M
Q4 24
$-66.7M
Q3 24
$-22.1M
$34.7M
Q2 24
$-36.7M
$34.2M
Gross Margin
MYGN
MYGN
VRRM
VRRM
Q1 26
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Operating Margin
MYGN
MYGN
VRRM
VRRM
Q1 26
23.2%
Q4 25
-2.7%
16.7%
Q3 25
-11.3%
28.6%
Q2 25
-154.5%
26.8%
Q1 25
-14.8%
25.7%
Q4 24
-18.6%
-19.6%
Q3 24
-9.4%
28.3%
Q2 24
-17.3%
27.5%
Net Margin
MYGN
MYGN
VRRM
VRRM
Q1 26
12.0%
Q4 25
7.3%
Q3 25
-13.3%
17.9%
Q2 25
-155.1%
16.3%
Q1 25
-0.1%
14.5%
Q4 24
-30.1%
Q3 24
-10.4%
15.4%
Q2 24
-17.4%
15.4%
EPS (diluted)
MYGN
MYGN
VRRM
VRRM
Q1 26
$0.17
Q4 25
$-0.09
$0.12
Q3 25
$-0.29
$0.29
Q2 25
$-3.57
$0.24
Q1 25
$0.00
$0.20
Q4 24
$-0.47
$-0.39
Q3 24
$-0.24
$0.21
Q2 24
$-0.41
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
VRRM
VRRM
Cash + ST InvestmentsLiquidity on hand
$149.6M
$46.9M
Total DebtLower is stronger
$119.9M
$34.1M
Stockholders' EquityBook value
$368.0M
$272.0M
Total Assets
$706.6M
$1.7B
Debt / EquityLower = less leverage
0.33×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
VRRM
VRRM
Q1 26
$46.9M
Q4 25
$149.6M
$65.3M
Q3 25
$145.4M
$196.1M
Q2 25
$74.4M
$147.7M
Q1 25
$91.8M
$108.5M
Q4 24
$102.4M
$77.6M
Q3 24
$99.9M
$206.1M
Q2 24
$97.3M
$122.0M
Total Debt
MYGN
MYGN
VRRM
VRRM
Q1 26
$34.1M
Q4 25
$119.9M
$1.0B
Q3 25
$119.5M
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
MYGN
MYGN
VRRM
VRRM
Q1 26
$272.0M
Q4 25
$368.0M
$293.0M
Q3 25
$372.8M
$403.1M
Q2 25
$388.1M
$352.1M
Q1 25
$704.9M
$299.6M
Q4 24
$701.1M
$265.1M
Q3 24
$731.7M
$486.5M
Q2 24
$740.5M
$438.6M
Total Assets
MYGN
MYGN
VRRM
VRRM
Q1 26
$1.7B
Q4 25
$706.6M
$1.6B
Q3 25
$728.1M
$1.8B
Q2 25
$677.3M
$1.7B
Q1 25
$1.0B
$1.6B
Q4 24
$1.0B
$1.6B
Q3 24
$1.1B
$1.9B
Q2 24
$1.1B
$1.8B
Debt / Equity
MYGN
MYGN
VRRM
VRRM
Q1 26
0.13×
Q4 25
0.33×
3.51×
Q3 25
0.32×
2.55×
Q2 25
2.93×
Q1 25
3.45×
Q4 24
3.90×
Q3 24
2.13×
Q2 24
2.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
VRRM
VRRM
Operating Cash FlowLast quarter
$10.6M
$40.8M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.53×
TTM Free Cash FlowTrailing 4 quarters
$104.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
VRRM
VRRM
Q1 26
$40.8M
Q4 25
$10.6M
$40.0M
Q3 25
$21.1M
$77.7M
Q2 25
$-13.6M
$75.1M
Q1 25
$-16.3M
$63.0M
Q4 24
$6.6M
$40.5M
Q3 24
$700.0K
$108.8M
Q2 24
$2.6M
$40.0M
Free Cash Flow
MYGN
MYGN
VRRM
VRRM
Q1 26
$9.6M
Q4 25
$5.7M
Q3 25
$49.0M
Q2 25
$40.3M
Q1 25
$41.7M
Q4 24
$21.6M
Q3 24
$85.1M
Q2 24
$26.0M
FCF Margin
MYGN
MYGN
VRRM
VRRM
Q1 26
4.3%
Q4 25
2.2%
Q3 25
18.7%
Q2 25
17.1%
Q1 25
18.7%
Q4 24
9.8%
Q3 24
37.7%
Q2 24
11.7%
Capex Intensity
MYGN
MYGN
VRRM
VRRM
Q1 26
Q4 25
13.3%
Q3 25
11.0%
Q2 25
14.8%
Q1 25
9.5%
Q4 24
8.5%
Q3 24
10.5%
Q2 24
6.3%
Cash Conversion
MYGN
MYGN
VRRM
VRRM
Q1 26
1.53×
Q4 25
2.12×
Q3 25
1.66×
Q2 25
1.95×
Q1 25
1.95×
Q4 24
Q3 24
3.13×
Q2 24
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

VRRM
VRRM

Government Solutions segment generated total$105.3M47%
Commercial Services segment generated total$97.8M44%
Parking Solutions segment generated total$20.4M9%

Related Comparisons